Back
Speaker illustration

Doctor Dina Labib

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)

Member of:

European Society of Cardiology

Presentations

CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic cardiomyopathy: risk prediction and outcomes

Access
Like
Thumbnail

Prevalence and predictors of right ventricular dysfunction in cancer patients treated with cardiotoxic chemotherapy - A prospective cardiovascular magnetic resonance study

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

Access
Like
Thumbnail

Value of baseline clinical and CMR characteristics for the prediction of cancer therapeutics-related cardiac dysfunction: results from the Cardiotoxicity Prevention Research Initiative (CAPRI)

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources